Prexton Therapeutics

develops novel therapeutic compounds for the treatment of brain disorders and CNS diseases...
Read more
Prexton Therapeutics Founder & CEO: François Conquet

Founder & CEO

François Conquet

CEO Approval Rating

75/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
250-500
Agree?
Funding
$72.8M

Prexton Therapeutics Competitors

1Addex
2Voyager
3Prothena
4PIQUR
5Minerva Neurosciences
6Sarepta
7Supernus
8Ambrx
9Avanir
10Surface Oncology

Trending Companies